In 2016, the Obama-Biden administration concluded that “the quality and strength of evidence” for medicalized gender transition was “low” and insufficient “to determine whether gender reassignment surgery improves health outcomes for Medicare beneficiaries with gender dysphoria.” Six years on, such skepticism has evaporated. In June, the Biden-Harris administration issued an executive order directing the departments of health and education to “promote expanded access to gender-affirming care.”